Nán Zhāng

Nán Zhāng serves as the Director of Global Scientific Communications at Alexion Pharmaceuticals, Inc., since 2021. Previously, Nán Zhāng held various positions at Eli Lilly and Company from 2014 to 2021, including Medical Lead in Medical Affairs, where responsibilities included new product launches, legacy product life-cycle management, and thought leader engagement. Additional roles at Eli Lilly involved managing publication strategies and regulatory document writing. Nán Zhāng was also the Academic Executive Editor at the Journal of Cardiovascular Disease Research from 2010 to 2014. Research experience includes a stint as a Research Scientist at The University of Texas Health Science Center at Houston, focusing on trauma and signaling mechanisms. Nán Zhāng holds a Ph.D. in Biomedical Sciences from The University of New Mexico and has completed post-doctoral training in Cardiovascular Science and Genomic Medicine.